MAA
IHE icon

Managed Account Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Managed Account Advisors’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$94K Buy
1,620
+444
+38% +$25.9K ﹤0.01% 2602
2015
Q1 		$68K Buy
+1,176
New +$64.3K ﹤0.01% 2581

Other funds holding IHE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BCM
Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return
AWA
ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
BWM
Braver Wealth Management Needham, Massachusetts $616M AUM 12.48% 1-Year Est. Return

Managed Account Advisors's IHE Position: Q2 2015 in Review

Managed Account Advisors increased its iShares US Pharmaceuticals ETF (IHE) stake by 38% in Q2 2015, buying an estimated $25.9K and bringing the position to 1,620 shares worth $94K. The position accounts for ﹤0.01% of the portfolio, ranked #2602.

Managed Account Advisors first reported a position in IHE in Q1 2015 and has held it in 2 quarters since. 120 funds tracked by Wall St. Rank hold IHE as of Q2 2015.

  • Managed Account Advisors held 1,620 shares of iShares US Pharmaceuticals ETF worth $94K as of Q2 2015.
  • Managed Account Advisors bought 444 iShares US Pharmaceuticals ETF shares in Q2 2015, an estimated $25.9K.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #2602 holding.
  • Managed Account Advisors first reported a position in iShares US Pharmaceuticals ETF in Q1 2015 and has held it in 2 quarters since.
  • 120 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.